These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 22578690)
1. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours. Schlieben P; Meyer A; Weise C; Bondzio A; Einspanier R; Gruber AD; Klopfleisch R Vet J; 2012 Nov; 194(2):210-4. PubMed ID: 22578690 [TBL] [Abstract][Full Text] [Related]
2. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours. Meyer A; Gruber AD; Klopfleisch R J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382 [TBL] [Abstract][Full Text] [Related]
3. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis. Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539 [TBL] [Abstract][Full Text] [Related]
4. Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours. Schlieben P; Meyer A; Weise C; Bondzio A; Gruber AD; Klopfleisch R J Comp Pathol; 2013 May; 148(4):318-22. PubMed ID: 22935087 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours. Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J Vet J; 2019 May; 247():71-74. PubMed ID: 30971355 [TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours. Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817 [TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours. Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872 [TBL] [Abstract][Full Text] [Related]
8. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137 [TBL] [Abstract][Full Text] [Related]
9. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells. Meyer A; Gruber AD; Klopfleisch R Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323 [TBL] [Abstract][Full Text] [Related]
10. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication. Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070 [TBL] [Abstract][Full Text] [Related]
11. Histologic grading of canine mast cell tumor: is 2 better than 3? Sabattini S; Scarpa F; Berlato D; Bettini G Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799 [TBL] [Abstract][Full Text] [Related]
12. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms. De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552 [TBL] [Abstract][Full Text] [Related]
13. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study. Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436 [TBL] [Abstract][Full Text] [Related]
14. Association of breed and histopathological grade in canine mast cell tumours. Mochizuki H; Motsinger-Reif A; Bettini C; Moroff S; Breen M Vet Comp Oncol; 2017 Sep; 15(3):829-839. PubMed ID: 27198171 [TBL] [Abstract][Full Text] [Related]
15. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis. Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941 [TBL] [Abstract][Full Text] [Related]
16. C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: From laboratory to clinic. Gil da Costa RM Vet J; 2015 Jul; 205(1):5-10. PubMed ID: 26021891 [TBL] [Abstract][Full Text] [Related]
17. Widespread mismatch repair protein expression in canine cutaneous mast cell tumors. Munday JS; French AF; Gibson IR; Gwynne K Vet Pathol; 2009 Mar; 46(2):227-32. PubMed ID: 19261633 [TBL] [Abstract][Full Text] [Related]
18. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours. Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858 [TBL] [Abstract][Full Text] [Related]
19. Mutation and methylation status of KIT and TP Vozdova M; Kubickova S; Fictum P; Cernohorska H; Fröhlich J; Rubes J Vet Comp Oncol; 2020 Sep; 18(3):438-444. PubMed ID: 31574575 [TBL] [Abstract][Full Text] [Related]
20. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers. Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]